Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution.

Abstract

SARS-CoV-2 vaccines are effective in preventing COVID-19. Patients with cancer are at high risk for severe COVID-19 and are appropriately prioritized for vaccination. Several studies in this issue of Cancer Cell add to our knowledge of the heterogeneity of immune responses to vaccination among patients with cancer and identify important areas for future research.

• Authors: Elizabeth A Griffiths, Brahm H Segal
• Journal: Cancer cell (Cancer Cell) Vol. 39 Issue 8 Pg. 1045-1047 (08 09 2021) ISSN: 1878-3686 [Electronic] United States
• PMID: 34242573 (Publication Type: Journal Article)
• Copyright: Copyright © 2021 Elsevier Inc. All rights reserved.

Chemical References

• COVID-19 Vaccines

Topics

• COVID-19 (epidemiology, immunology, prevention & control)
• COVID-19 Vaccines (administration & dosage, immunology)
• Humans
• Immunity
• Neoplasms (epidemiology, immunology)
• Public Health Surveillance
• SARS-CoV-2 (immunology)